// App-Quantinova.ai

P4-01-19 : The combined detection of CTC and serum HER2 ECD predict PFS for HER2-positive advanced breast cancer patients

Researchers

Presenter

  • Jiang Z

Principal Investigators

  • Zhou J

  • Wang TLiu YLi L

  • Zhang H

  • Zhang S

  • Bian L

  • Song S

Medical Centers

  • Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • Ecdysoneless

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved